Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors. [electronic resource]
Producer: 20171010Description: 236-239 p. digitalISSN:- 2146-8427
- Carcinoma, Basal Cell -- chemically induced
- Carcinoma, Squamous Cell -- chemically induced
- Cost-Benefit Analysis
- Drug Costs
- Drug Substitution
- Graft Rejection -- immunology
- Graft Survival
- Humans
- Immunosuppressive Agents -- adverse effects
- Kidney Transplantation -- adverse effects
- Medical Records
- Neoplasm Recurrence, Local
- Protein Kinase Inhibitors -- adverse effects
- Retrospective Studies
- Risk Factors
- Sarcoma, Kaposi -- chemically induced
- Skin Neoplasms -- chemically induced
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.